Sponsored Content by Society for Laboratory Automation and Screening Feb 1 2023 Thought LeadersMagdalena KasendraDirector of Research and DevelopmentCenter for Stem Cell and Organoid Medicine In this interview, we speak to Magdalena Kasendra, Director of Research and Development at the CuSTOM Accelerator, about organoid technology and how it has the power to revolutionize healthcare through the development of new, effective drugs and tissue replacement therapies.
What I find most exciting about this field is the potential for organoids to revolutionize healthcare. The ability to grow functional, three-dimensional organoids in a dish opens up a whole new world of possibilities for studying disease, developing new therapies, and understanding how cells and tissues function.
Our ultimate goal is to improve human health, and I am dedicated to ensuring that our research has a real impact on patients. We are constantly seeking new collaborations and partnerships to help us achieve this goal and bridge the gap between basic research and clinical application. Our efforts at CuSTOM are focused on utilizing organoids to improve human health. We believe this research can transform the way we treat a wide range of human diseases and disorders in the future. By creating new treatments and therapies tailored to the individual patient, we aim to enhance the effectiveness and safety of these treatments and ultimately unlock better healthcare for all.
Furthermore, our multidisciplinary team plays a critical role in bridging the gap between basic research and clinical application and accelerates the translation of new discoveries into treatments and therapies that can improve health outcomes for millions worldwide. It is a key driver in advancing medical research and providing innovative solutions to improve patient outcomes and quality of life.The drug discovery sector has seen incredible advancements in recent years.
You are giving a talk at SLAS 2023 titled 'Engineering next generation organoids for biomedical research and drug development'. Please can you talk us through what you will be covering in this talk and what listeners can expect to learn? Related StoriesIn my talk at SLAS 2023, I will discuss the latest advances in organoid technology and how we are using these advances to improve biomedical research and drug development.
With continued research and investment, we can hope to see personalized medicine becoming more commonplace in healthcare settings and see this approach's benefits reach more patients. This can lead to more effective and efficient treatments, fewer side effects, and improved patient outcomes. Additionally, personalized medicine can help to reduce healthcare costs by avoiding unnecessary treatments and reducing the number of ineffective drugs.